Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Tecnimede-Sociedade Tecnico-Medicinal S.A.
Sponsor

Tecnimede-Sociedade Tecnico-Medicinal S.A.

Portugal Rua Da Tapada Grande 2 Abrunheira, 2710-228, Portugal

About the sponsor

Tecnimede-Sociedade Tecnico-Medicinal S.A. has active clinical research in type 2 diabetes-related treatment areas, with work centered on empagliflozin, canagliflozin, and alogliptin formulations. This includes interest in SGLT2 inhibitors and DPP-4 inhibitors used in glycaemic management.

  • Empagliflozin
  • Canagliflozin
  • Alogliptin
  • SGLT2 inhibitor
  • DPP-4 inhibitor

The sponsor also investigates combination-related therapeutic areas involving glucose-lowering agents, reflecting a focus on oral treatments for metabolic disease.

About Specializations

Tecnimede-Sociedade Tecnico-Medicinal S.A. runs clinical trials in conditions such as Type 2 diabetes mellitus, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Type 2 diabetes mellitus

Not yet recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Alogliptin
  • Sponsor:Tecnimede-Sociedade Tecnico-Medicinal S.A.

A study to compare how the body absorbs empagliflozin tablets in healthy individuals.

Not recruiting
Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · Healthy volunteers
  • Substances:Empagliflozin
  • Sponsor:Tecnimede-Sociedade Tecnico-Medicinal S.A.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.